https://de.marketscreener.com/kurs/aktie/CORCEPT-THERAPEUTICS-INCO-40449488/news/Corcept-schlie-t-Rekrutierung-in-Phase-2-Studie-mit-Dazals-bei-Patienten-mit-amyotropher-Lateralskl-46437990/?utm_source=telegram&utm_medium=social&utm_campaign=share